CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in research as a growth hormone secretagogue and is often studied alongside Ipamorelin. Research use only.
What CJC-1295 is
CJC-1295 is a peptide modeled on GHRH, the natural signal that prompts growth hormone release. It is designed to be longer-acting than natural GHRH, which is part of why it draws research interest. Some versions are described as "with DAC" or "no DAC," referring to a modification that changes its duration.
How it is studied
In the laboratory, CJC-1295 is studied in research, frequently in combination with Ipamorelin, a pairing covered in CJC-1295 and Ipamorelin. As a research peptide, it is a study tool and is not approved or intended for human use.
Browse research-grade peptides
Every Axis compound is third-party tested to 99.4%+ purity, with a certificate of analysis on every batch.
What to look for
A research-grade CJC-1295 should ship with a batch-specific certificate of analysis. For comparisons, see Sermorelin vs. CJC-1295 and CJC-1295 vs. Ipamorelin.
Key takeaways
- CJC-1295 is a synthetic GHRH analog.
- It is a growth hormone secretagogue studied in research.
- It is often studied alongside Ipamorelin.
- Research-grade CJC-1295 is supplied for research use only.
A note on research use
The peptides supplied by Axis Peptide Labs are reference compounds for laboratory and research use only. They are intended for qualified researchers working in academic, institutional, and analytical settings. They are not drugs, foods, cosmetics, or medical products, and they are not intended for human or veterinary consumption. Documented identity and documented purity are what matter most when sourcing a compound, both of which are published on the Axis certificates of analysis page.
